Study Notes on Receptors and Intracellular Signaling I
Overview of Receptor and Intracellular Signaling Mechanisms
Lecture delivered by Colin Sumners, PhD.
Main Objective: Review how hormones affect target cells through specific receptors and intricate signaling mechanisms, ultimately leading to diverse physiological actions such as metabolism regulation, growth, and reproduction.
Specific Objectives
General Principles: Understanding the fundamental concepts of receptors, ligands, and the general architecture of signaling pathways.
Receptor Classification: Discussing the different categories of receptors based on their cellular location, molecular structure, and an insight into their subtypes, characteristics, and the high degree of specificity they exhibit for their respective ligands.
Intracellular Signaling: Introduction to the intricate cascade of events by which cell surface receptors transduce extracellular signals into intracellular responses, mediating vital cellular functions.
Hormones and Their Actions on Target Tissues
Receptor Location & Specificity: Hormone action occurs via specific receptors found exclusively on or within target cells. This specificity ensures that only cells equipped with the appropriate receptor will respond to a given hormone.
Cellular Communication: Hormones released from an Endocrine Gland or Nerve Cell travel through the bloodstream to act upon distant Target Cells (e.g., kidney involved in water balance, liver in glucose metabolism, muscle in energy utilization, bone in calcium homeostasis).
Physiological Action Example: For instance, insulin (a hormone) binds to insulin receptors (denoted as R) primarily on liver, muscle, and adipose cells, triggering glucose uptake and storage, thereby lowering blood glucose levels.
Types of Hormones Based on Solubility
Water Soluble, Lipid Insoluble Hormones (e.g., peptide hormones, catecholamines like epinephrine)
Receptor Location: Due to their inability to cross the lipid bilayer, their receptors are located on the cell surface (plasma membrane). Binding triggers an intracellular signaling cascade.
Lipid Soluble, Water Insoluble Hormones (e.g., steroid hormones like cortisol, thyroid hormones, vitamin D)
Receptor Location: These hormones can readily diffuse across the plasma membrane and bind to intracellular receptors located in the cytoplasm or nucleus.
Each hormone's unique chemical structure dictates its solubility and, consequently, the specific location of its receptor at the target cells, ensuring precise and controlled biological responses.
đź’ˇ Memorization Tip: "Lipid loves the inside (intracellular), Water stays outside (cell surface)."
Table 1: Hormone Types and Receptor Location
Hormone Type | Solubility | Receptor Location | Examples |
|---|---|---|---|
Water Soluble, Lipid Insoluble | High in water, Low in lipid | Cell Surface (Plasma Membrane) | Peptide hormones (e.g., insulin), Catecholamines (e.g., epinephrine) |
Lipid Soluble, Water Insoluble | Low in water, High in lipid | Intracellular (Cytoplasm or Nucleus) | Steroid hormones (e.g., cortisol, estrogen), Thyroid hormones (, ), Vitamin D |
Latency & Duration of Hormone Action
Hormonal actions can vary significantly in their speed of onset and duration:
Rapid Signaling (milliseconds to seconds): Eliciting immediate effects by modifying the activity of pre-existing proteins. Examples include:
Enzyme Activation/Inhibition: Rapid phosphorylation or dephosphorylation of enzymes.
Ion Channel Modulation: Opening or closing of ion channels, altering membrane potential and cellular excitability (e.g., neurotransmitter actions).
Slow (Genomic) Signaling (minutes to hours or days): Leading to changes in gene expression and the subsequent synthesis of new proteins. This involves:
Gene Transcription: Activation or repression of specific genes.
Protein Synthesis: Production of new enzymes, channel proteins, regulatory proteins, or structural proteins, leading to long-term physiological changes (e.g., growth and development effects of growth hormone or steroid hormones).
Amplification of Hormonal Responses
Hormonal actions at target cells are crucial for generating significant biological outcomes even with low hormone concentrations. This is achieved through a signal amplification cascade where a single hormone molecule can initiate a vast intracellular response via successive generations of signaling molecules:
Example:
1 molecule of hormone binds to its receptor.
This activates multiple effector enzymes (e.g., adenylyl cyclase).
Each activated enzyme can then catalyze the formation of many molecules of a second messenger (e.g., ).
These second messengers, in turn, activate multiple downstream protein kinases or other target proteins, which can modify thousands of other target proteins, leading to a much larger cellular response (e.g., ).
This amplification ensures sensitivity and robustness of cellular responses to extracellular signals.
đź’ˇ Memorization Tip: "The more steps, the more AMPlification!" (Think of the increase in cAMP as part of the amplification process).
Receptor Classification
1. Cell Surface Receptors
These receptors are integral membrane proteins that bind to ligands that cannot easily cross the plasma membrane. They are crucial for signaling by small proteins, peptides, amino acids, and related small molecules (such as amines and growth factors):
Subtypes Include:
G protein-coupled receptors (GPCRs): The largest family of cell surface receptors, characterized by their seven transmembrane segments. They couple to intracellular G proteins to initiate signaling cascades by regulating diverse effector proteins. Also known as seven-transmembrane (7TM) receptors or metabotropic receptors.
đź’ˇ Memorization Tip: For GPCRs, remember "7 Segments Through Membrane" or "Seven Times Maybe" to recall 7TM.
Ionotropic (ion channel-linked) receptors: Ligand-gated ion channels that directly open or close in response to ligand binding, leading to rapid changes in ion permeability and membrane potential (e.g., nicotinic acetylcholine receptor).
đź’ˇ Memorization Tip: "Ionotropic = Instant gates for Ions." They directly alter membrane potential.
Catalytic (enzyme-linked) receptors: Possess intrinsic enzyme activity or are directly associated with enzymes. Upon ligand binding, they often phosphorylate intracellular proteins, initiating signaling cascades. Examples include receptor tyrosine kinases (RTKs) such as the insulin receptor.
đź’ˇ Memorization Tip: "Catalytic = Catalyzes reactions." They have inherent or associated enzyme activity.
2. Intracellular Receptors
Typically found within the cytoplasm or nucleus, these receptors bind to lipid-soluble hormones such as steroid hormones (e.g., estrogen, testosterone), thyroid hormones (, ), and vitamin D metabolites.
Upon ligand binding, these receptors often undergo a conformational change, translocate to the nucleus (if initially cytoplasmic), and directly bind to specific DNA sequences (hormone response elements, HREs) to regulate gene transcription, thus directly affecting protein synthesis.
Table 2: Receptor Classification Overview
Receptor Class | Cellular Location | Ligand Type | Mechanism of Action | Examples |
|---|---|---|---|---|
Cell Surface Receptors | Plasma Membrane | Small proteins, peptides, amino acids, amines, growth factors | Initiate intracellular signaling cascades without entering the cell | GPCRs, Ionotropic Receptors, Catalytic Receptors |
- G Protein-Coupled Receptors (GPCRs) | Plasma Membrane | Wide variety (hormones, neurotransmitters, photons, odorants) | Activate G proteins, which then modulate effector enzymes/ion channels | Adrenergic receptors, Muscarinic receptors, Peptide receptors |
- Ionotropic (Ion Channel-Linked) | Plasma Membrane | Neurotransmitters (e.g., Acetylcholine, GABA, Glutamate) | Directly open/close ion channels upon ligand binding, altering membrane potential | Nicotinic acetylcholine receptor |
- Catalytic (Enzyme-Linked) | Plasma Membrane | Growth factors, insulin | Intrinsic enzymatic activity (e.g., tyrosine kinase) or associate with enzymes; often phosphorylate proteins | Receptor Tyrosine Kinases (e.g., Insulin Receptor) |
Intracellular Receptors | Cytoplasm or Nucleus | Lipid-soluble hormones (Steroids, Thyroid hormones, Vitamin D) | Ligand-receptor complex binds to DNA, regulating gene transcription | Steroid hormone receptors, Thyroid hormone receptors |
G Protein-Coupled Receptors (GPCR)
Diversity of GPCRs: These receptors mediate responses to an incredibly diverse array of signaling molecules, from photons and odorants to hormones and neurotransmitters.
Adrenergic Receptors (α and β): Bind Catecholamines like Epinephrine (Epi) and Norepinephrine (NE), regulating heart rate, blood pressure, and metabolism.
Muscarinic Receptors: Bind Acetylcholine, affecting smooth muscle contraction, glandular secretion, and heart rate.
Peptide/Glycoprotein Receptors: Such as:
Vasopressin receptors (V1, V2): Regulate water balance and blood pressure.
Parathyroid Hormone receptor: Involved in calcium homeostasis.
Angiotensin II receptors (AT1, AT2): Crucial for blood pressure regulation and fluid balance.
Somatostatin receptors: Modulate hormone secretion.
Follicle Stimulating Hormone (FSH) receptor: Essential for reproductive functions.
Calcium Receptors (CaR): Detect extracellular calcium levels, influencing parathyroid hormone secretion and kidney function.
General Characteristics of GPCRs:
They all share a common structural motif: a single polypeptide chain that traverses the plasma membrane seven times (7TM).
The third intracellular loop and the C-terminal tail of the receptor are critical for binding and activating specific heterotrimeric G proteins.
Over 1000 members recognized in the GPCR family, highlighting their evolutionary success and functional importance.
GPCR Subtypes
The existence of multiple subtypes for a single hormone allows for diverse and specific responses in different target tissues. These subtypes confer specificity and fine-tune physiological actions.
Adrenergic Receptors: For example, adrenergic receptors each couple to different G proteins and thus elicit distinct cellular responses.
Vasopressin Receptors: V1 receptors primarily mediate vasoconstriction, while V2 receptors mediate water reabsorption in the kidneys.
AT1/AT2 Receptors: Specific for Angiotensin II, with AT1 mediating most of the known effects of Angiotensin II (e.g., vasoconstriction, aldosterone release), and AT2 often having opposing or modulatory roles.
Muscarinic Receptors: (M1-M5) influence various functions in the central and peripheral nervous systems.
Each receptor’s specificity is intricately defined by the precise three-dimensional structure of the receptor binding site, which enables a "key-and-lock" fit with the hormone, ensuring precise action on target cells.
Cross-reactivity can occur when hormones with similar chemical structures bind to unintended receptors, potentially leading to off-target effects.
Example: Mineralocorticoid receptors (MR), primarily designed for aldosterone, can also bind glucocorticoid hormones (e.g., cortisol) with high affinity, leading to mineralocorticoid effects under conditions of high cortisol. This cross-binding is often regulated by enzyme systems that deactivate glucocorticoids locally.
Cross-binding potential is also noted in adrenergic receptors with various catecholamines.
Table 3: GPCR Subtypes and Examples
GPCR Subtype | Example Hormones/Ligands | Key Physiological Actions (Examples) |
|---|---|---|
Adrenergic Receptors () | Epinephrine (Epi), Norepinephrine (NE) | Regulate heart rate, blood pressure, metabolism (e.g., fight-or-flight response) |
Muscarinic Receptors (M1-M5) | Acetylcholine (ACh) | Affect smooth muscle, glandular secretion, heart rate, CNS functions |
Vasopressin Receptors (V1, V2) | Vasopressin (ADH) | V1: Vasoconstriction; V2: Water reabsorption in kidneys |
Parathyroid Hormone Receptor | Parathyroid Hormone (PTH) | Calcium homeostasis by affecting bone, kidney |
Angiotensin II Receptors (AT1, AT2) | Angiotensin II | Blood pressure regulation, fluid balance (vasoconstriction, aldosterone release) |
Somatostatin Receptors | Somatostatin | Modulate hormone secretion (e.g., growth hormone, insulin) |
Follicle Stimulating Hormone (FSH) Receptor | Follicle Stimulating Hormone (FSH) | Essential for reproductive functions (gamete production, hormone synthesis) |
Calcium Receptors (CaR) | Extracellular | Detect levels, influencing PTH secretion, kidney function |
Activation of GPCR and Signal Transduction
Step 1: Activation Cycle of G Protein
Resting State: In the inactive state, the heterotrimeric G protein (composed of , and subunits) is bound to GDP on its subunit and is associated with the GPCR.
Ligand Binding: Upon binding of an appropriate ligand (hormone or neurotransmitter) to the GPCR, the receptor undergoes a conformational change.
GEF Activity: This activated GPCR acts as a Guanine Nucleotide Exchange Factor (GEF), promoting the release of GDP from the G subunit and allowing the binding of GTP (Guanosine Triphosphate).
Dissociation: GTP binding causes the G subunit to dissociate from both the GPCR and the G dimer. Both the GTP-bound G subunit and the G dimer become active signaling molecules, free to interact with various downstream effector enzymes or ion channels, thus initiating downstream signaling pathways.
Step 2: Signal Mediation by G Protein Subunits
The activated G subunit (GTP-bound) or the G dimer can interact with various effector enzymes or ion channels, leading to the production of intracellular second messengers or direct modulation of cellular processes:
Adenylyl Cyclase (AC) Pathway:
G (stimulatory): The activated G subunit binds to and activates adenylyl cyclase, an enzyme that catalyzes the conversion of ATP to cyclic AMP (cAMP). Increased cAMP levels activate Protein Kinase A (PKA), leading to phosphorylation of target proteins.
đź’ˇ Memorization Tip: "G for Stimulation" (of adenylyl cyclase leading to cAMP).
G (inhibitory): The activated G subunit binds to and inhibits adenylyl cyclase, thereby decreasing cAMP levels and reducing PKA activity.
đź’ˇ Memorization Tip: "G for Inhibition" (of adenylyl cyclase leading to decreased cAMP).
Phospholipase C (PLC) Pathway (G):
The activated G subunit stimulates Phospholipase C- (PLC), an enzyme that hydrolyzes phosphatidylinositol 4,5-bisphosphate (), a membrane phospholipid.
This hydrolysis generates two key second messengers:
Inositol trisphosphate (): A water-soluble molecule that diffuses into the cytoplasm and binds to receptors on the endoplasmic reticulum (ER), triggering the release of stored into the cytoplasm.
Diacylglycerol (DAG): A lipid-soluble molecule that remains in the plasma membrane and, together with , activates Protein Kinase C (PKC), which then phosphorylates various target proteins.
đź’ˇ Memorization Tip: "G for Quick calcium release and Quite a lot of DAG!" (PLC breaks into and DAG).
Phospholipase A2 (PLA2) Involvement:
Certain G proteins (e.g., G, G) can also activate Phospholipase A2, which catalyzes the release of arachidonic acid from membrane phospholipids. Arachidonic acid is a precursor for a variety of lipid mediators including prostaglandins and leukotrienes (eicosanoids), which have diverse physiological roles (e.g., inflammation, pain).
GPCR Signaling Cascades - Summary
The binding of a hormone to its specific GPCR initiates a complex cascade of events, leading to the production of crucial second messengers within the cell. These second messengers, such as cAMP, /DAG, and arachidonic acid derivatives, then propagate and amplify the original signal.
This results in:
Modulation of Protein Kinases: Activation or inhibition of enzymes like PKA, PKC, and others, leading to phosphorylation of a multitude of target proteins.
Altered Downstream Effectors: Changes in enzyme activity, gene expression, and ion channel function.
The immense variability in GPCRs, G protein subtypes, effector enzymes, and second messengers allows for highly diverse hormonal responses, manifesting in a wide range of physiological effects like changes in ion channel activity, glandular secretion, smooth muscle contraction, and profound alterations in gene transcription and cellular metabolism.
Main Second Messengers (GPCRs): cAMP, /DAG, and Arachidonic Acid derivatives.
đź’ˇ Memorization Tip: Think "CAD" for the main second messengers!
Table 4: GPCR Signaling Cascades (Summarized)
G-protein Type | Effector Enzyme | Second Messenger(s) | Key Downstream Effectors | Physiological Outcome (General) |
|---|---|---|---|---|
G | Adenylyl Cyclase (AC) | Cyclic AMP (cAMP) | Protein Kinase A (PKA) | Enzyme activation, gene expression, ion channel modulation |
G | Adenylyl Cyclase (AC) | Cyclic AMP (cAMP) | Protein Kinase A (PKA) | Enzyme inhibition, reduced gene expression |
G | Phospholipase C- (PLC) | Inositol Trisphosphate (), Diacylglycerol (DAG) | release (from ER), Protein Kinase C (PKC) activation | Smooth muscle contraction, secretion, enzyme activation |
G (some cases) | Phospholipase A2 (PLA2) / Ion Channels | Arachidonic Acid (AA) & derivatives | Lipid mediators (eicosanoids) / Direct channel modulation | Inflammation, pain, ion permeability changes |
Conclusory Points
Hormones exquisitely alter physiological function by binding to highly specific receptors. The location of these receptors—whether on the plasma membrane (for water-soluble hormones) or intracellularly (for lipid-soluble hormones)—dictates the initial steps of the signaling process.
These initial binding events then orchestrate complex intracellular responses through intricate signaling pathways, particularly involving major families like GPCRs and their associated effector molecules and second messengers.
Regulatory Implications: A deep understanding of these intricate molecular mechanisms is not only fundamental to comprehending normal physiological processes but is also crucially important for the development of pharmacological and therapeutic interventions. Many drugs specifically target hormonal and receptor signaling pathways (e.g., beta-blockers for hypertension, antidiabetic drugs targeting insulin signaling) to either enhance or inhibit specific cellular responses and treat a wide array of diseases.